International Agency for Research on Cancer (IARC) - Summaries & Evaluations
N'-NITROSOANABASINE (NAB)
VOL.: 37 (1985) (p. 225)
CAS Nos: 37620-20-5; 1133-64-8; 84237-39-8
Chem. Abstr. Name: Pyridine, 3-(1-nitroso-2-piperidinyl)-;
pyridine, 3-(1-nitroso-2-piperidinyl)-,(S)-;
pyridine, 3-(1-nitroso-2-piperidinyl), (+,-)-
5. Summary of Data Reported and Evaluation
5.1 Exposures
N'-Nitrosoanabasine (NAB) has been found in tobacco products
(chewing tobacco and snuff) and in mainstream smoke from cigarettes.
Thus, there is widespread exposure to NAB among users of tobacco
products.
5.2 Experimental data
NAB was tested for carcinogenicity by oral administration in two
strains of rats and by subcutaneous injection in hamsters. In rats,
it induced oesophageal carcinomas and/or papillomas. The study in
hamsters was inadequate for evaluation.
No data were available on mutagenic or related effects of NAB.
5.3 Human data
No case report or epidemiological study of the carcinogenicity of
NAB to humans was available to the Working Group.
5.4 Evaluation
There is limited evidence for the carcinogenicity of
N'-nitrosoanabasine to experimental animals.
No data on humans were available.
For definition of the italicized terms, see Preamble Evaluation.
Subsequent evaluation: Suppl. 7 (1987) (p. 67: Group 3)
Synonym
Last updated: 21 April 1998